Rational treatment of acute rhinosinusitis in the context of increasing antibiotic resistance.

IF 1 Q3 OTORHINOLARYNGOLOGY
Magdalena Arcimowicz
{"title":"Rational treatment of acute rhinosinusitis in the context of increasing antibiotic resistance.","authors":"Magdalena Arcimowicz","doi":"10.5604/01.3001.0054.7506","DOIUrl":null,"url":null,"abstract":"<p><p>Acute rhinosinusitis is one of the most common diseases in the population, both in primary and specialist otolaryngological care. It is also responsible for a disturbingly high percentage of prescribed antibiotic therapy, regardless of the etiology of the disease. Despite the fact that acute viral and acute postviral rhinosinusitis dominate among the phenotypes of acute rhinosinusitis, and the development of acute bacterial rhinosinusitis occurs in only 0.5-2% of all cases in adults and 5-10% in children, antibiotics still remain an important element of treatment, despite alarming data on the growing antibiotic resistance and the adverse effect of antibiotics on the human microbiome, leading to dysbiosis. The discovery of antibiotics was one of the greatest achievements of modern medicine, but their inappropriate use leads to the gradual increase in the phenomenon of antibiotic resistance, considered one of the most serious public health problems, recognized by the WHO as one of the 10 greatest threats to human health in the 21&lt;sup&gt;st&lt;/sup&gt; century. The unjustified use of antibiotics in outpatient care is the key to the growth of this problem, in parallel with the lack of patient compliance. The COVID pandemic has intensified this unfavourable trend. That is why the knowledge of antibiotic stewardship is so important. According to the guidelines, in the therapy of acute rhinosinusitis, symptomatic and anti-inflammatory treatment dominates, and antibiotic therapy has very strictly defined and limited indications. The latest guidelines also recommend herbal medicines, including BNO 1016, in the treatment of acute viral and postviral rhinosinusitis. Available studies indicate that it has a beneficial effect not only on shortening the duration of the disease and reducing symptoms, but also reduces the need for antibiotic treatment in acute rhinosinusitis. Complications of acute rhinosinusitis are relatively rare and are not related to taking antibiotics.</p>","PeriodicalId":42608,"journal":{"name":"Polish Journal of Otolaryngology","volume":"78 6","pages":"1-11"},"PeriodicalIF":1.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polish Journal of Otolaryngology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5604/01.3001.0054.7506","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Acute rhinosinusitis is one of the most common diseases in the population, both in primary and specialist otolaryngological care. It is also responsible for a disturbingly high percentage of prescribed antibiotic therapy, regardless of the etiology of the disease. Despite the fact that acute viral and acute postviral rhinosinusitis dominate among the phenotypes of acute rhinosinusitis, and the development of acute bacterial rhinosinusitis occurs in only 0.5-2% of all cases in adults and 5-10% in children, antibiotics still remain an important element of treatment, despite alarming data on the growing antibiotic resistance and the adverse effect of antibiotics on the human microbiome, leading to dysbiosis. The discovery of antibiotics was one of the greatest achievements of modern medicine, but their inappropriate use leads to the gradual increase in the phenomenon of antibiotic resistance, considered one of the most serious public health problems, recognized by the WHO as one of the 10 greatest threats to human health in the 21<sup>st</sup> century. The unjustified use of antibiotics in outpatient care is the key to the growth of this problem, in parallel with the lack of patient compliance. The COVID pandemic has intensified this unfavourable trend. That is why the knowledge of antibiotic stewardship is so important. According to the guidelines, in the therapy of acute rhinosinusitis, symptomatic and anti-inflammatory treatment dominates, and antibiotic therapy has very strictly defined and limited indications. The latest guidelines also recommend herbal medicines, including BNO 1016, in the treatment of acute viral and postviral rhinosinusitis. Available studies indicate that it has a beneficial effect not only on shortening the duration of the disease and reducing symptoms, but also reduces the need for antibiotic treatment in acute rhinosinusitis. Complications of acute rhinosinusitis are relatively rare and are not related to taking antibiotics.

在抗生素耐药性不断增加的情况下合理治疗急性鼻窦炎。
急性鼻炎是人群中最常见的疾病之一,无论是在初级治疗还是耳鼻喉专科治疗中都是如此。无论疾病的病因如何,它也是导致抗生素治疗处方比例高得令人不安的原因。尽管急性病毒性鼻炎和急性病毒后鼻炎在急性鼻炎的表型中占主导地位,而急性细菌性鼻炎仅占成人病例总数的 0.5%-2%,儿童病例的 5%-10%,但抗生素仍然是治疗的重要因素,尽管抗生素耐药性和抗生素对人体微生物组的不良影响不断增加,导致菌群失调的数据令人担忧。抗生素的发现是现代医学最伟大的成就之一,但抗生素的不当使用导致抗生素耐药性现象逐渐增加,被认为是最严重的公共卫生问题之一,并被世界卫生组织认定为 21<sup>st</sup> 世纪人类健康的十大威胁之一。在门诊治疗中不合理使用抗生素是导致这一问题加剧的关键所在,与此同时,患者也缺乏依从性。COVID 大流行加剧了这一不利趋势。这就是抗生素管理知识如此重要的原因。根据指南,在急性鼻炎的治疗中,对症和抗炎治疗占主导地位,抗生素治疗有非常严格的定义和有限的适应症。最新指南还推荐使用中草药(包括 BNO 1016)治疗急性病毒性和病毒后鼻炎。现有研究表明,BNO 1016 不仅对缩短病程和减轻症状有好处,还能减少急性鼻炎患者对抗生素治疗的需求。急性鼻炎的并发症相对较少,与服用抗生素无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Polish Journal of Otolaryngology
Polish Journal of Otolaryngology OTORHINOLARYNGOLOGY-
CiteScore
1.30
自引率
16.70%
发文量
15
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信